The antiherpesvirus action of phosphonoacetate.
D000818:Animals; D000998:Antiviral Agents; D002470:Cell Survival / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D004352:Drug Resistance, Microbial; D004790:Enzyme Induction; D006564:Herpesviridae / Q000187:drug effects* / Q000378:metabolism; D006566:Herpesviridae Infections / Q000188:drug therapy; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D009154:Mutation; D019384:Nucleic Acid Synthesis Inhibitors; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D013045:Species Specificity; D014740:Vidarabine / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D019384:Nucleic Acid Synthesis Inhibitors; D009943:Organophosphorus Compounds; D001084:Vidarabine Phosphate; D014740:Vidarabine; D007065:Idoxuridine; D010746:Phosphonoacetic Acid